P.A.W. Capital Corp Pfizer Inc Transaction History

P.A.W. Capital Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $91,500 - $113,380	2,000 Added 12.5%	18,000 $932,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $82,640 - $122,500	-2,000 Reduced 11.11%	16,000 $945,000
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $157,000 - $201,680	-4,000 Reduced 18.18%	18,000 $774,000
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $133,960 - $151,080	4,000 Added 22.22%	22,000 $797,000
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $63,500 - $74,500	-2,000 Reduced 10.0%	18,000 $661,000
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $75,300 - $91,350	2,500 Added 14.29%	20,000 $654,000
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $81,225 - $105,325	2,500 Added 16.67%	17,500 $629,000
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $38,470 - $43,860	-1,000 Reduced 6.25%	15,000 $655,000
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $68,940 - $83,620	-2,000 Reduced 11.11%	16,000 $705,000
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $65,960 - $70,320	-2,000 Reduced 10.0%	18,000 $653,000
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $620,000 - $683,000	20,000	20,000 $714,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.